Skip to content

Investigating the Role of Retinoic Acid Metabolizing Bacteria in Dysregulating the Microgut Biome in Favor of Pathogenic Species

A novel approach and corresponding compounds to treat gut diseases where retinoic acid plays a role in disease homeostasis and progression

Published: 9th November 2022
Investigating the Role of Retinoic Acid Metabolizing Bacteria in Dysregulating the Microgut Biome in Favor of Pathogenic Species
Kateryna_Kon, https://stock.adobe.com/uk/193474886, stock.adobe.com
Patents
  • US Patent 10,874,634, “Compounds and methods for inhibiting CYP26 enzymes”
  • US Patent 11,364,220, “Compounds and methods for inhibiting CYP26 enzymes”
  • Pending Canadian Patent Application Serial No. 3,047,433, “Compounds and Methods for Inhibiting Cyp26 Enzymes”
IP Status
  • Patented
Seeking
  • Seeking investment
  • University spin out
  • Licensing
  • Commercial partner